Cargando…

Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study

BACKGROUND: An excess risk of Bell's palsy has been suggested after mRNA vaccines. We examined the association between the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy. METHODS: Using the database of the largest healthcare provider in Israel, we retrieved data from different periods in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibli, Rana, Barnett, Ofra, Abu-Full, Zomoroda, Gronich, Naomi, Najjar-Debbiny, Ronza, Doweck, Ilana, Rennert, Gad, Saliba, Walid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566165/ https://www.ncbi.nlm.nih.gov/pubmed/34751262 http://dx.doi.org/10.1016/j.lanepe.2021.100236

Ejemplares similares

Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study
por: Tomkins-Netzer, Oren, et al.
Publicado: (2022)

Red cell distribution width and all-cause mortality in patients with atrial fibrillation: A cohort study
por: Saliba, Walid, et al.
Publicado: (2017)

Association of atrial fibrillation and cancer: Analysis from two large population-based case-control studies
por: Saliba, Walid, et al.
Publicado: (2018)

Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
por: Hertz, Tomer, et al.
Publicado: (2023)

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021)

Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2022)

Bell’s palsy following COVID-19 vaccination
por: Colella, Giuseppe, et al.
Publicado: (2021)

Vaccines and Bell's palsy: A narrative review
por: Bertin, Blandine, et al.
Publicado: (2023)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

The association between COVID-19 vaccination and Bell's palsy
por: Cirillo, Nicola, et al.
Publicado: (2022)

Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy
por: Repajic, Michael, et al.
Publicado: (2021)

Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine
por: Saleh, Ola Ali, et al.
Publicado: (2022)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Management of COVID-19 post-vaccine Bell's palsy in an outpatient
por: Cellina, Michaela, et al.
Publicado: (2022)

Bell's Palsy and COVID-19 Vaccination: A Systematic Review
por: Shahsavarinia, Kavous, et al.
Publicado: (2022)

Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report
por: Yu, Bin-Yan, et al.
Publicado: (2021)

Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine
por: Amir, Ofra, et al.
Publicado: (2022)

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
por: Mevorach, Dror, et al.
Publicado: (2021)

COVID-19 vaccine – Long term immune decline and breakthrough infections
por: Khoury, Johad, et al.
Publicado: (2021)

Bell palsy
por: Patel, Matthew, et al.
Publicado: (2022)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story
por: Cirillo, Nicola, et al.
Publicado: (2021)

Association between Influenza Vaccination and the Risk of Bell’s Palsy in the Korean Elderly
por: Jeong, Nayoung, et al.
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Bell's palsy: case report
Publicado: (2021)

Bell's palsy following COVID-19 vaccine administration in HIV+ patient
por: Mussatto, Caroline C., et al.
Publicado: (2022)

Bell’s palsy following COVID-19 vaccination: a case report()
por: Gómez de Terreros Caro, G., et al.
Publicado: (2021)

Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

BNT162b2 mRNA Vaccine Interference with Co-Administration of Tdap Vaccine
por: Chilimuri, Sridhar, et al.
Publicado: (2021)

Tyrosine kinase-targeting drugs-associated heart failure
por: Gronich, N, et al.
Publicado: (2017)

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)

Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine
por: Roca, B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d863kdcioju0lkllivaqg2u57d